Sodium Carbonate → Physostigmine
Reaction equation
[CH3:1][C@:2]12[C:9]3[CH:10]=[C:11]([O:14][C:15]([NH:17][CH3:18])=[O:16])[CH:12]=[CH:13][C:8]=3[N:7]([CH3:19])[C@H:6]1[N:5]([CH3:20])[CH2:4][CH2:3]2.C1C=CC(O)=C(C(O)=O)C=1.C([O-])([O-])=O.[Na+].[Na+]>ClCCl.O>[CH3:1][C@:2]12[C:9]3[CH:10]=[C:11]([O:14][C:15]([NH:17][CH3:18])=[O:16])[CH:12]=[CH:13][C:8]=3[N:7]([CH3:19])[C@H:6]1[N:5]([CH3:20])[CH2:4][CH2:3]2Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a heterogeneous mixture of physostigmine salicylate (450 g) in dichloromethane (1.35L) and water (1.35L) was added Na2CO3 (150 g) over 0.5-1.0 hour while maintaining 18°-20° C. During the addition the pH of the aqueous phase increases from 5.5 to 9.5. After stirring at 18°-20° C. for 0.5 hour the aqueous phase was separated and extracted with dichloromethane (2×112 mL). The combined dichloromethane phase was treated again with water (500 mL) and Na2CO3 (23 g) at 18°-20° C. and stiffed for 0.5 hour. The aqueous phase was separated, extracted with dichloromethane (2×112 mL) and the combined dichloromethane phases were washed with water (450 mL), dried over K2CO3 (20 g) and concentrated under reduce pressure below 30° C. to give 302 g of crystalline physostigmine free base (100.8% of theory, 99.0% HPLC purity).
Workup
- temperaturewhile maintaining 18°-20° C
- additionDuring the addition the pH of the aqueous phase
- temperatureincreases from 5.5 to 9.5
- customwas separated
- extractionextracted with dichloromethane (2×112 mL)
- additionThe combined dichloromethane phase was treated again with water (500 mL) and Na2CO3 (23 g) at 18°-20° C.
- waitstiffed for 0.5 hour
- customThe aqueous phase was separated
- extractionextracted with dichloromethane (2×112 mL)
- washthe combined dichloromethane phases were washed with water (450 mL)
- dry with materialdried over K2CO3 (20 g)
- concentrationconcentrated
- custompressure below 30° C.
Sources & evidence
- ORD record
- ord-ca543a15df40455a9a36932f289305de
- Source dataset
- uspto-grants-1996_03
- Patent number
- US05498726
Reaction notes
Loading…